Moreover, we tried to unveil the most relevant molecular pathways involved in KRAS-mediated pancreatic tumor development by taking advantage of transgenic zebrafish reporter lines expressing responsive elements known to be pathway specific (supplementary material Fig. S4) (Moro et al., 2013). The gene discussed is KRAS; the disease is pancreatic neoplasm.